Wei Wei

28.0k total citations · 5 hit papers
574 papers, 20.9k citations indexed

About

Wei Wei is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Wei Wei has authored 574 papers receiving a total of 20.9k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Molecular Biology, 142 papers in Biomedical Engineering and 94 papers in Oncology. Recurrent topics in Wei Wei's work include Nanoparticle-Based Drug Delivery (64 papers), Nanoplatforms for cancer theranostics (59 papers) and Immunotherapy and Immune Responses (37 papers). Wei Wei is often cited by papers focused on Nanoparticle-Based Drug Delivery (64 papers), Nanoplatforms for cancer theranostics (59 papers) and Immunotherapy and Immune Responses (37 papers). Wei Wei collaborates with scholars based in China, United States and Australia. Wei Wei's co-authors include Guanghui Ma, Hua Yue, Zhiguo Su, Shuang Wang, Feng Li, Piping Lv, Zhanguo Yue, Xiaoyong Gao, Weier Bao and Lian-Yan Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Wei Wei

552 papers receiving 20.7k citations

Hit Papers

Immunomodulation‐Enhanced... 2019 2026 2021 2023 2020 2019 2019 2020 2024 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wei Wei 7.0k 6.9k 4.5k 3.7k 2.6k 574 20.9k
Andrew Z. Wang 7.3k 1.0× 5.4k 0.8× 2.8k 0.6× 6.8k 1.8× 1.6k 0.6× 268 16.2k
Mauro Ferrari 9.6k 1.4× 7.4k 1.1× 4.3k 1.0× 8.2k 2.2× 1.6k 0.6× 260 20.7k
Fabian Kießling 11.6k 1.7× 6.9k 1.0× 3.6k 0.8× 7.4k 2.0× 2.3k 0.9× 481 26.3k
Guangjun Nie 10.2k 1.5× 10.8k 1.6× 5.1k 1.1× 5.7k 1.5× 3.4k 1.3× 355 24.6k
Huile Gao 9.2k 1.3× 7.5k 1.1× 3.2k 0.7× 8.5k 2.3× 2.0k 0.8× 279 19.0k
Wei Tao 12.9k 1.9× 9.3k 1.3× 7.8k 1.7× 7.1k 1.9× 2.3k 0.9× 273 26.1k
Twan Lammers 12.1k 1.7× 7.3k 1.1× 4.1k 0.9× 10.5k 2.9× 2.2k 0.8× 332 24.8k
Jae Hyung Park 9.0k 1.3× 7.9k 1.2× 3.7k 0.8× 10.2k 2.8× 1.3k 0.5× 730 30.2k
Hao Wang 8.3k 1.2× 7.2k 1.0× 5.7k 1.3× 5.8k 1.6× 1.7k 0.7× 702 22.3k
Seungpyo Hong 5.9k 0.8× 6.5k 0.9× 2.7k 0.6× 6.0k 1.6× 942 0.4× 159 15.0k

Countries citing papers authored by Wei Wei

Since Specialization
Citations

This map shows the geographic impact of Wei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wei more than expected).

Fields of papers citing papers by Wei Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wei. The network helps show where Wei Wei may publish in the future.

Co-authorship network of co-authors of Wei Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wei. A scholar is included among the top collaborators of Wei Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wei. Wei Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Wei, et al.. (2025). Expression and Diagnostic Value of Nrf2 and p62 in Cervical Squamous Cell Carcinoma and Intraepithelial Lesions. Cancer Management and Research. Volume 17. 1005–1013. 1 indexed citations
2.
Li, Quanxiao, Meng Jin, Zhen Ding, et al.. (2024). Renal Clearable Nanodots‐Engineered Erythrocytes with Enhanced Circulation and Tumor Accumulation for Photothermal Therapy of Hepatocellular Carcinoma. Small. 20(25). e2309278–e2309278. 7 indexed citations
3.
Jia, Bo, Xinquan Gu, Ming Li, et al.. (2024). Engineered Nanobodies Elicit Durable and Robust Bi‐Therapeutic Efficacy Toward Virus and Tumors. Advanced Functional Materials. 34(46). 2 indexed citations
4.
Liu, Yang, et al.. (2024). PKC-θ is an important driver of fluoride-induced immune imbalance of regulatory T cells/effector T cells. The Science of The Total Environment. 934. 173081–173081. 4 indexed citations
5.
Wei, Wei, et al.. (2024). Low-temperature treatment optimization for diesel-contaminated kaolin: Mutual impacts of generated pyrolytic carbon and particle agglomeration. Environmental Pollution. 363(Pt 2). 125196–125196. 1 indexed citations
6.
Wei, Wei, Hang Sun, Bingwei Yang, Erqun Song, & Yang Song. (2024). Coronal ApoE Protein Combines with LRP1 to Inactivate GSK3β That Mitigates Silica Nanoparticle-Induced Brain Lesion. ACS Chemical Neuroscience. 15(4). 808–815. 2 indexed citations
7.
Liu, Huanhuan, Lijuan Chen, Yan Bai, et al.. (2023). Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions. Theranostics. 13(6). 1974–2014. 78 indexed citations
8.
Wang, Zhe, Chuanjie Zhang, Jiaqi Meng, et al.. (2023). A Targeted Exosome Therapeutic Confers Both CfDNA Scavenging and Macrophage Polarization for Ameliorating Rheumatoid Arthritis. Advanced Materials. 35(48). e2302503–e2302503. 58 indexed citations
9.
Li, Feng, Yuan Yang, Hua Yue, et al.. (2023). Microneedle patch loaded with ferritin-nanocaged doxorubicin for locally targeted drug delivery and efficient skin cancer treatment. Particuology. 88. 282–289. 9 indexed citations
10.
Lu, Guihong, Feng Li, Shuang Wang, et al.. (2022). Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma. Nature Communications. 13(1). 4214–4214. 147 indexed citations
11.
Mok, Rebecca S.F., Taimoor I. Sheikh, Isabella Rodrigues Fernandes, et al.. (2022). Wide spectrum of neuronal and network phenotypes in human stem cell-derived excitatory neurons with Rett syndrome-associated MECP2 mutations. Translational Psychiatry. 12(1). 450–450. 15 indexed citations
12.
Mian, Agrima, Wei Wei, Brian T. Hill, et al.. (2021). Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel. Transplantation and Cellular Therapy. 27(3). S307–S307. 2 indexed citations
13.
Yang, Xin, Yan Chen, You Zhou, et al.. (2021). GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion. Oncogene. 40(25). 4307–4323. 15 indexed citations
14.
Bao, Weier, Ming Liu, Jiaqi Meng, et al.. (2021). MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload. Nature Communications. 12(1). 6399–6399. 172 indexed citations
15.
Lv, Yanlin, Feng Li, Shuang Wang, et al.. (2021). Near-infrared light–triggered platelet arsenal for combined photothermal-immunotherapy against cancer. Science Advances. 7(13). 88 indexed citations
16.
Mian, Agrima, Wei Wei, Allison Winter, et al.. (2019). Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis. Blood. 134(Supplement_1). 4452–4452. 5 indexed citations
17.
Zhao, Yan, et al.. (2019). Comparison of two optical zones in visual quality after femtosecond laser-assisted LASIK. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Wei, Wei, et al.. (2019). MiR-1284 suppresses gastric cancer progression by targeting EIF4A1. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Qi, Ruogu, Yongheng Wang, Peter M. Bruno, et al.. (2017). Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer. Nature Communications. 8(1). 2166–2166. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026